Inmagene
San Diego, US · Founded 2019 · 50 employees on LinkedIn · 2 known investors
Find your way into Inmagene
Sign up to see every warm intro you have to Inmagene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inmagene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company leverages its management team's extensive experience in drug development and commercialization across all stages.
Investors · 2
Frequently asked questions
- What does Inmagene do?
- ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company leverages its management team's extensive experience in drug development and commercialization across all stages.
- Who are Inmagene's investors?
- Inmagene's investors include G Vision Capital, Vertex Ventures China.
- Where is Inmagene headquartered?
- Inmagene is headquartered in San Diego, US.
